Among those tested, anti-GAD antibodies were detected with ELISA—but not CBA—in low (< 2000 IU/ml) titers, as typically seen in Type-I diabetes, but not > 2000 IU/ml, as seen in GAD-spectrum neurological disorders [17]. The gene discussed is GAD1; the disease is type 1 diabetes mellitus.